NYSEMKT: MTNB
Matinas Biopharma Holdings Inc Stock Ownership - Who owns Matinas Biopharma Holdings?

Insider buying vs selling

Have Matinas Biopharma Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adam K. Stern10% Owner2026-07-10344,710$0.35
$120.65kBuy
Adam K. Stern10% Owner2026-07-10630,335$0.35
$220.62kBuy
Adam K. Stern10% Owner2025-10-3192,100$0.65
$59.40kBuy

1 of 1

MTNB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MTNB insiders and whales buy or sell their stock.

MTNB Shareholders

What type of owners hold Matinas Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adam K. Stern61.28%9,004,115$1.64MInsider
Herbert J. Conrad58.56%8,604,510$1.57MInsider
Roelof Rongen24.09%3,539,416$644.17kInsider
Jennifer Lorenzo14.20%2,086,576$379.76kInsider
Raphael J. Mannino13.07%1,919,715$349.39kInsider
Abdel A. Fawzy11.71%1,720,186$313.07kInsider
Jerome D. Jabbour5.72%840,011$152.88kInsider
James S. Scibetta4.42%649,958$118.29kInsider
Stefano Ferrari3.78%555,547$101.11kInsider
Patrick G. Lepore2.72%400,000$72.80kInsider

1 of 3

MTNB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MTNB0.00%100.00%Net BuyingNet Buying
CRIS0.02%99.98%Net Buying
JUNS0.01%99.99%
GNPX0.01%99.99%Net Selling
VBIO0.03%99.97%Net Buying

Matinas Biopharma Holdings Stock Ownership FAQ

Who owns Matinas Biopharma Holdings?

Matinas Biopharma Holdings (NYSEMKT: MTNB) is owned by 0.00% institutional shareholders, 203.99% Matinas Biopharma Holdings insiders, and 0.00% retail investors. Adam K. Stern is the largest individual Matinas Biopharma Holdings shareholder, owning 9.00M shares representing 61.28% of the company. Adam K. Stern's Matinas Biopharma Holdings shares are currently valued at $1.64M.

If you're new to stock investing, here's how to buy Matinas Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.